These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
295 related items for PubMed ID: 11469460
1. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F. J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460 [Abstract] [Full Text] [Related]
2. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity. Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159 [Abstract] [Full Text] [Related]
3. Hyperprolactinemia in males with systemic lupus erythematosus. Mok CC, Lau CS, Lee KW, Wong RW. J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430 [Abstract] [Full Text] [Related]
4. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Leaños-Miranda A, Cárdenas-Mondragón G. Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247 [Abstract] [Full Text] [Related]
5. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Leaños-Miranda A, Chávez-Rueda KA, Blanco-Favela F. Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926 [Abstract] [Full Text] [Related]
7. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Leaños A, Pascoe D, Fraga A, Blanco-Favela F. Lupus; 1998 Apr; 7(6):398-403. PubMed ID: 9736323 [Abstract] [Full Text] [Related]
8. Altered diurnal rhythm of prolactin in systemic sclerosis. Hilty C, Brühlmann P, Sprott H, Gay RE, Michel BA, Gay S, Neidhart M. J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228 [Abstract] [Full Text] [Related]
9. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome. Leaños-Miranda A, Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Parra A, Ramírez-Peredo J. Lupus; 2007 Sep; 16(5):342-9. PubMed ID: 17576736 [Abstract] [Full Text] [Related]
10. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. Neidhart M. J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986 [Abstract] [Full Text] [Related]
11. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. J Rheumatol; 1996 Apr; 23(4):629-32. PubMed ID: 8730116 [Abstract] [Full Text] [Related]
12. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays. Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A. J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622 [Abstract] [Full Text] [Related]
13. Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to disease activity and CNS manifestations. El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S. J Rheumatol; 1996 Feb; 23(2):374-7. PubMed ID: 8882050 [Abstract] [Full Text] [Related]
14. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR. J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507 [Abstract] [Full Text] [Related]
15. [Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia]. Leaños Miranda L, Bustos López HH, Fraga Mouret A, Blanco Favela F, Dalila Pascoe Lira ME, Dalila Pascoe Lira C. Ginecol Obstet Mex; 1998 May; 66():179-86. PubMed ID: 9646575 [Abstract] [Full Text] [Related]
16. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Senécal JL, Rauch J, Grodzicky T, Raynauld JP, Uthman I, Nava A, Guimond M, Raymond Y. Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261 [Abstract] [Full Text] [Related]
17. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E. Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371 [Abstract] [Full Text] [Related]
18. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R. J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [Abstract] [Full Text] [Related]
19. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G. Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [Abstract] [Full Text] [Related]
20. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus. Rovenský J, Juránková E, Rauová L, Blazícková S, Lukác J, Veselková Z, Jezová D, Vigas M. J Rheumatol; 1997 Dec; 24(12):2330-4. PubMed ID: 9415637 [Abstract] [Full Text] [Related] Page: [Next] [New Search]